Physician profile
Almog Gal
NPI 1225338650
$1,111.73
in general payments reported to CMS, 2019-2025
19 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.21 · 2020: $159 · 2021: $161 · 2022: $14.54 · 2023: $271 · 2024: $277 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $227.35 | 2020-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $210.00 | 2021-2025 | Ozempic |
| Axsome Therapeutics, INC. | $149.65 | 2024-2025 | Auvelity |
| Currax Pharmaceuticals LLC | $84.77 | 2019-2021 | |
| Exact Sciences Corporation | $52.02 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $49.13 | 2020 | |
| Merck Sharp & Dohme LLC | $43.62 | 2019-2020 | |
| Amgen INC. | $42.68 | 2024 | Otezla, Repatha, Krystexxa |
| Lilly USA, LLC | $41.81 | 2020-2021 | |
| Intra-Sana Laboratories | $35.78 | 2023-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Nevro Corp. | $34.39 | 2024 | Senza |
| Abbvie INC. | $29.50 | 2023-2024 | |
| Sonex Health, INC. | $22.48 | 2025 | Sx-One Microknife |
| Biohaven Pharmaceuticals, INC. | $20.67 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.05 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $14.54 | 2022 | |
| Eisai INC. | $12.25 | 2021 | |
| Apria Healthcare LLC | $12.14 | 2021 | |
| Phathom Pharmaceuticals, INC. | $11.90 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Almog Gal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.